Давид Аркадир

Научные публикации

• Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study
• Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme
• Low prevalence of SCA27B in adult-onset cerebellar ataxia cohort of Jewish ancestry
• Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study
• Subthalamic nucleus input-output dynamics are correlated with Parkinson's burden and treatment efficacy
• Perception of emotionally incongruent cues: evidence for overreliance on body vs. face expressions in Parkinson's disease
• Delayed levodopa-responsive parkinsonism following acute midbrain injury
• Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
• Novel RAB39B Mutation Causes Parkinsonism in Males with Developmental Disorder
• Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants
• Manganese Accumulation in the Brain
• Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project
• Reply to: "Subthalamic Physiology in Genetic Subtypes of Parkinson's Disease"
• High Frequency of LRRK2 R1441C Pathogenic Variant Among Palestinian-Arabs
• Has Parkinson Disease Gone to the Dogs?
• Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
• The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology
• The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
• Management of advanced Parkinson's disease in Israel: Clinicians viewpoint and action items
• A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk
• Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects
• The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis
• Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson Disease
• Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
• Deep Brain Stimulation Can Differentiate Subregions of the Human Subthalamic Nucleus Area by EEG Biomarkers
• Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing
• Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study
• Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease
• Machine learning-based personalized subthalamic biomarkers predict ON-OFF levodopa states in Parkinson patients
• Parkinson's Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers
• Independently together: subthalamic theta and beta opposite roles in predicting Parkinson's tremor
• A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders
• Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
• Neurological misdiagnoses of lymphoma
• Benign SLC39A14 Course of Dystonia-Parkinsonism Secondary to Inherited Manganese Accumulation
• Reader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss
• Opposing patterns of abnormal D1 and D2 receptor dependent cortico-striatal plasticity explain increased risk taking in patients with DYT1 dystonia
• The definition of neuronopathic Gaucher disease
• A Real-Life Search for the Optimal Set of Conversion Factors to Levodopa-Equivalent-Dose in Parkinson's Disease Patients on Polytherapy
• Movement context modulates neuronal activity in motor and limbic-associative domains of the human parkinsonian subthalamic nucleus
• Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus
• α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls
• A machine learning algorithm successfully screens for Parkinson's in web users
• Substrate reduction therapy for GBA1-associated Parkinsonism: Are we betting on the wrong mouse?
• Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease
• MYORG Mutations: a Major Cause of Recessive Primary Familial Brain Calcification
• DEEP BRAIN STIMULATION FOR OBSESSIVE COMPULSIVE DISORDER: CASE REPORT OF THE FIRST OCD PATIENT IN ISRAEL
• Using global team science to identify genetic parkinson's disease worldwide
• Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease
• MYORG is associated with recessive primary familial brain calcification
• Increased energy expenditure during posture maintenance and exercise in early Parkinson disease
• Subthalamic theta activity: a novel human subcortical biomarker for obsessive compulsive disorder
• Glucosylsphingosine is a reliable response biomarker in Gaucher disease
• One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression
• Corrigendum: Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia
• Deep Brain Stimulation in Parkinson's Disease and Essential Tremor: In Search of Lost Time
• Local vs. volume conductance activity of field potentials in the human subthalamic nucleus
• Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia
• Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development
• Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations
• Anesthesia reduces discharge rates in the human pallidum without changing the discharge rate ratio between pallidal segments
• DYT1 dystonia increases risk taking in humans
• Relative preservation of finger flexion in amyotrophic lateral sclerosis
• Teaching NeuroImages: hypertrophic olivary degeneration in a young man with POLG gene mutation
• In quest of the oscillator(s) in tremor: are we getting closer?
• Pure hereditary spastic paraplegia due to a de novo mutation in the NIPA1 gene
• Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease
• Lipoid proteinosis with bilateral amygdalae calcifications, headache, and cognitive impairments
• The balance and gait disorder of essential tremor: what does this mean for patients?
• Applause sign in clinically overlapping diseases: a case of TDP-43 proteinopathy
• Intraarterial multi-modal reperfusion therapy for acute ischemic stroke: a10 year single-center experience
• Aggressive leptomeningeal gliomatosis in neurofibromatosis type 1
• Multimodal reperfusion therapy for large hemispheric infarcts in octogenarians: is good outcome a realistic goal?
• Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke
• Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke
• Stent-assisted thrombolysis in acute tandem carotid and middle cerebral arteries occlusion
• Stent for temporary endovascular bypass and thrombectomy in major ischemic stroke
• Decompressive hemicraniectomy improves outcome in patients with failed arterial recanalization after acute carotid artery occlusion
• Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in Israel
• Akineto-rigid vs. tremor syndromes in Parkinsonism
• Encoding by response duration in the basal ganglia
• Lack of spike-count and spike-time correlations in the substantia nigra reticulata despite overlap of neural responses
• Statistical properties of pauses of the high-frequency discharge neurons in the external segment of the globus pallidus
• Shaping of motor responses by incentive values through the basal ganglia
• Midbrain dopamine neurons encode decisions for future action
• Independent coding of movement direction and reward prediction by single pallidal neurons
• Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons